CK
PFE icon

Carnick & Kubik’s Pfizer PFE Stock Holding History

Carnick & Kubik’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$89K Buy
+3,168
New +$90.5K 0.03% 569
2015
Q4 		– Sell
-3,168
Closed -$94.4K – 255
2015
Q3 		$94.4K Buy
+3,168
New +$102K 0.07% 176
2013
Q4 		– Sell
-16,144
Closed -$440K – 159
2013
Q3 		$440K Sell
16,144
-106
-0.7% -$2.88K 0.67% 64
2013
Q2 		$432K Buy
+16,250
New +$449K 0.53% 73

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carnick & Kubik's PFE Position: Q1 2016 in Review

Carnick & Kubik opened a new position in Pfizer (PFE) in Q1 2016: 3,168 shares worth $89K. The stake represents 0.03% of the portfolio and ranks #569 among its holdings. This is a return to the name: Carnick & Kubik previously reported a position in PFE as recently as Q3 2015.

Carnick & Kubik first reported a position in PFE in Q2 2013 and has held it in 4 quarters since. The position peaked at $440K in Q3 2013. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

  • Carnick & Kubik held 3,168 shares of Pfizer worth $89K as of Q1 2016.
  • Pfizer was a new Carnick & Kubik position in Q1 2016.
  • Pfizer made up 0.03% of Carnick & Kubik's portfolio in Q1 2016, its #569 holding.
  • Carnick & Kubik first reported a position in Pfizer in Q2 2013 and has held it in 4 quarters since.
  • Carnick & Kubik's Pfizer position peaked at $440K in Q3 2013.
  • 1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.